Analyst Ratings for TransMedics Group (TMDX)
TMDX Rating Summary
TMDX Price Target Summary
- Highest: $145.00 (Jefferies)
- Lowest: $65.00 (Stifel)
- Average: $109.27
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$109.27 (+26.5%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 73%
Avg. $ Target:
$109.27 (+26.5%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 73%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/28/2026 | UBS » Updated 8/5/2026 |
Patrick Wood | New Coverage | Neutral (N/A) |
77.00 (80.00) |
74.28 (86.40) |
16.32% | Details |
| 5/6/2026 | Oppenheimer | Suraj Kalia | Downgrade | Perform (Outperform) |
N/A (N/A) |
94.93 (86.40) |
-8.99% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
